According to information from a stock market online community, below are the performance results of the 5 major subsidiaries under HYBE Labels in the first half of 2024.
- Source Music (Artist(s): LE SSERAFIM) -- Sales: 35,159,236,000 KRW (~ $25,828,000 USD) / Net income: 6,098,879,000 KRW (~ $ 4,480,000 USD)
- ADOR (Artist(s): NewJeans) -- Sales: 61,466,068,000 KRW (~ $45,154,000 USD) / Net income: 11,030,377,000 KRW (~ $8,103,000 USD)
- Pledis (Artist(s): Seventeen, fromis_9, TWS) -- Sales: 158,325,808,000 KRW (~ $116,308,000 USD) / Net income: 27,502,347,000 KRW (~ $20,204,000 USD)
- BeLift Lab (Artist(s): ENHYPEN, ILLIT) -- Sales: 55,043,874,000 KRW (~ $40,436,000 USD) / Net income: 15,944,158,000 KRW (~ $11,713,000 USD)
- Big Hit (Artist(s): BTS, TOMORROW x TOGETHER) -- Sales: 164,700,000,000 KRW (~ $120,991,000 USD) / Net income: 48,000,000,000 KRW (~ $35,262,000 USD)
Korean netizens on an online K-Pop community responded with comments like,
"I wonder how much NewJeans will make if they went on a world tour."
"Pledis and BeLift Lab both have huge differences in sales and income because they launched rookie teams."
"Based on numbers alone, it doesn't make sense why any of the big wigs at HYBE would want Min Hee Jin out..."
"Okay but NewJeans came back in May so they made that much in like 2 months..?"
"BeLift stop pocketing the money for yourselves and invest some in the boys!!"
"BeLift is doing surprisingly well."
"Thinking back on how poorly BeLift treats the boys... this makes me mad all over again."
"They didn't include KOZ because KOZ had losses??"
"KOZ reported a net loss of 800 million KRW (~ 587,690 USD) from launching BOYNEXTDOOR."
"If ADOR can make that much with a girl group alone, imagine them tripling it with a boy group... HYBE why are you so dumb."
"Even with the new group launch and fromis_9 hanging in there, the difference between sales and income for Pledis is too much..."
SEE ALSO: Pre-orders for BTS's 5th full album 'Arirang' surpass 4 million copies just one week after opening
SHARE
SHARE
